Akèy › Limfadenopati Imunoblastik › Texas › Houston
Etid klinik pou Limfadenopati Imunoblastik nan Houston, TX
4 etid pou Limfadenopati Imunoblastik ap chèche patisipan nan sit nan ak bò kote Houston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
Ap rekriteFaz 3
- MD Anderson Cancer Center, Houston
A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.
Ap rekriteFaz 1
- Clinical Trial Site, Houston
A Registry for People With T-cell Lymphoma
Ap rekriteEtid obsèvasyon
- MD Anderson Cancer Center (Data Collection Only), Houston
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
Ap rekriteFaz 1
- The University of Texas MD Anderson Cancer Center, Houston
Etid Limfadenopati Imunoblastik nan lòt vil
- New York City, NY5 etid
- Chicago, IL4 etid
- Miami, FL4 etid
- Durham, NC4 etid
- Baldwin Park, CA3 etid
- Ann Arbor, MI3 etid
- Boston, MA3 etid
- New Haven, CT3 etid
- Atlanta, GA3 etid
- Columbus, OH3 etid
- St. Louis, MO3 etid
- Edison, NJ3 etid
Lòt etid nan Houston
- Kansè Poumon ki pa ti selil145 etid
- Kansè nan tete126 etid
- Kansè (tout kalite)121 etid
- Kansè Metastatik104 etid
- Kansè kolorektal102 etid
- Kansè ovè89 etid
- Leksemi mieloïd egi85 etid
- Kansè poumon78 etid
- Kansè pwostat76 etid
- Kansè Endomèt68 etid
- Kansè pankreyas61 etid
- Melanom59 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.